ArticleAlimentary pharmacology & therapeutics2023

Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.

Nabeel Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.